Swiss National Bank’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.89M | Sell |
124,300
-1,300
| -1% | -$40.7K | ﹤0.01% | 1430 |
|
|
2025
Q1 | $4.21M | Sell |
125,600
-1,000
| -0.8% | -$33.6K | ﹤0.01% | 1355 |
|
|
2024
Q4 | $4.96M | Buy |
126,600
+1,300
| +1% | +$51K | ﹤0.01% | 1342 |
|
|
2024
Q3 | $4.93M | Sell |
125,300
-800
| -0.6% | -$31.5K | ﹤0.01% | 1334 |
|
|
2024
Q2 | $4.92M | Buy |
126,100
+2,300
| +2% | +$89.7K | ﹤0.01% | 1294 |
|
|
2024
Q1 | $5.33M | Hold |
123,800
| – | – | ﹤0.01% | 1263 |
|
|
2023
Q4 | $5.7M | Buy |
123,800
+12,100
| +11% | +$557K | ﹤0.01% | 1214 |
|
|
2023
Q3 | $3.82M | Buy |
111,700
+1,900
| +2% | +$64.9K | ﹤0.01% | 1443 |
|
|
2023
Q2 | $4.23M | Buy |
109,800
+8,500
| +8% | +$327K | ﹤0.01% | 1413 |
|
|
2023
Q1 | $3.63M | Sell |
101,300
-11,400
| -10% | -$408K | ﹤0.01% | 1455 |
|
|
2022
Q4 | $4.44M | Buy |
112,700
+4,300
| +4% | +$170K | ﹤0.01% | 1388 |
|
|
2022
Q3 | $3.91M | Buy |
108,400
+600
| +0.6% | +$21.7K | ﹤0.01% | 1424 |
|
|
2022
Q2 | $3.28M | Buy |
107,800
+10,300
| +11% | +$313K | ﹤0.01% | 1585 |
|
|
2022
Q1 | $2.98M | Buy |
97,500
+10,100
| +12% | +$309K | ﹤0.01% | 1788 |
|
|
2021
Q4 | $2.73M | Buy |
87,400
+24,000
| +38% | +$750K | ﹤0.01% | 1847 |
|
|
2021
Q3 | $969K | Buy |
63,400
+1,500
| +2% | +$22.9K | ﹤0.01% | 2450 |
|
|
2021
Q2 | $1.15M | Sell |
61,900
-2,100
| -3% | -$39.1K | ﹤0.01% | 2423 |
|
|
2021
Q1 | $1.15M | Buy |
64,000
+1,500
| +2% | +$26.9K | ﹤0.01% | 2295 |
|
|
2020
Q4 | $961K | Hold |
62,500
| – | – | ﹤0.01% | 2308 |
|
|
2020
Q3 | $692K | Hold |
62,500
| – | – | ﹤0.01% | 2270 |
|
|
2020
Q2 | $784K | Buy |
+62,500
| New | +$784K | ﹤0.01% | 2240 |
|